Correlation p53 expression and human papilloma virus deoxyribonucleic acid with clinical outcome in early uterine cervical carcinoma

Cancer Detection and Prevention

Volumn 29, Issue 6, 2005, Pages 528-536

  Ikuta, Akiko ^a   Saito, Junko ^a   Mizokami, Tomomi ^a   Nakamoto, Tsuyoshi ^a   Yasuhara, Masahiro ^a   Nagata, Fumie ^a   Nakajima, Mayumi ^a   Matsuo, Izumi ^a   Yasuda, Katsuhiko ^a   Kanzaki, Hideharu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Clinical outcome; Hormonal status; HPV DNA; Human papilloma virus (HPV); Immunohistochemical study; Metastases; p53; Prognosis; Recurrence; Uterine cervical carcinoma

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; FEMALE; GENE OVEREXPRESSION; GENETIC CORRELATION; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MEDICAL ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; WART VIRUS;

ADULT; AGE FACTORS; BLOTTING, WESTERN; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 28744456594     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2005.09.002     Document Type: Article

References (60)

1. P. Pisani, F. Bray, and D.M. Parkin Estimates of the world-wide prevalence of cancer for 25 sites in the adult population Int J Cancer 97 2002 72 81
2. A.J. Levine, M.E. Perry, and A. Chang The 1993 Walter Hubert Lecture: the role of the p53 tumor-suppressor gene in tumorigenesis Br J Cancer 69 1994 409 416
3. M. Tommasino, R. Accardi, and S. Caldeira The role of TP53 in cervical carcinogenesis Hum Mutat 21 2003 307 312
4. M. Hollstein, D. Sidransky, and B. Vogelstein p53 Mutations in human cancers Science 253 1991 49 53
5. Walboomers JMM, M.V. Jacobs, and M.M. Manos Human papilloma virus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
6. H. zur Hauzen Papilloma viruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 2002 342 350
7. N. Muñoz Human papilloma virus and cancer: the epidemiological evidence J Clin Virol 19 2000 1 5
8. A.J. Levine The p53 tumor-suppressor gene N Eng J Med 14 1992 1350 1352
9. A.J. Levine, J. Momand, and C.A. Finlay The p53 tumour suppressor gene Nature 351 1991 453 456
10. M.S. Greenblatt, W.P. Bennett, and M. Hollstein Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis Cancer Res 54 1994 4855 4878
11. M.F. Kohler, B.J.M. Kerns, and P.A. Humphrey Mutation and overexpression of p53 in early-stage epithelial ovarian cancer Obstet Gynecol 81 1993 643 650
12. L.R. Livingstone, A. White, and J. Sprouse Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 Cell 70 1992 923 935
13. W.S. Ahn, Y.J. Han, and S.M. Bae Differential suppression of human cervical cancer cell growth by adenovirus delivery of p53 in vitro: arrest phase of cell cycle is dependent on cell line Jpn J Caner Res 93 2002 1012 1019
14. M.J.T. Verstegen, D. Troost, and S. Leenstra Proliferation- and apoptosis-related proteins in intracranial ependymomas: an immunohistochemical analysis J Neuro-oncol 56 2002 21 28
15. F. Algaba, I. Trias, and A. Santinelli TP53 in urologic tumors AQCH 25 2003 123 130
16. WAF1/CIP1 in early cervical carcinoma: correlation with clinical outcome Int J Gynecol Cancer 12 2002 290 298
17. W. Kedzia, M. Schmidt, and A. Frankowski Immunohistochemical assay of p53, cyclin D1, c-erbB2, EGFr and Ki-67 proteins in HPV-positive and HPV-negative cervical cancers Folia Histochem Cytobiol 40 2002 37 41
18. T. Crook, D. Wrede, and J.A. Tidy Clonal p53 mutation in primary cervical cancer: association with human papilloma virus-negative tumors Lancet 339 1992 1070 1073
19. B.A. Werness, A.J. Levine, and P.M. Howley Association of human papilloma virus types 16 and 18 E6 proteins with p53 Science 248 1990 76 79
20. M. Akasofu, and Y. Oda Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papilloma virus types 16 and 18 Virchow Archiv 425 1995 593 602
21. M. Oka, K. Kounoura, and F. Narasaki P-glycoprotein is positively correlated with p53 protein accumulation in human colorectal cancers Jpn J Cancer Res 88 1997 738 742
22. C.A. Perez, R.J. Kurman, F.B. Stehman, and J.T. Thipgen Uterine cervix W.J. Hoskins C.A. Perez R.C. Young Principles and practice of gynecologic oncology 1993 Lippincott Philadelhpia 591 662
23. Y.S. Fu, and J.W. Reagan Pathology of the uterine cervix, vagina, and vulva J.L. Bennington Major problems in pathology 1989 WB Saunders Philadelphia, PA 269 277
24. R.K. Saiki, S. Scharf, and F. Faloona Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia Science 230 1985 1350 1354
25. A.M. Roda Husman, J.M. Walboomers, and C.J. Meijer Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papilloma virus genotypes, using polymerase chain reaction Int J Cancer 56 1994 802 806
26. H. Yoshikawa, T. Kawana, and K. Kitagawa Detection and typing of multiple genital human papilloma viruses by DNA amplification with consensus primers Jpn J Cancer Res 82 1991 524 531
27. L.W. Huang, Y.Y. Chou, and S.L. Chao p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome Gynecol Oncol 83 2001 348 354
28. E.H. Åvall-Lundqvist, C. Silfverswärd, and U. Aspenblad The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma Eur J Cancer 33 1997 1799 1804
29. H.Y. Chen, C.T. Hsu, and W.C. Lin Prognostic value of p53 expression in stage IB1 cervical carcinoma Gynecol Obstet Invest 49 2000 266 271
30. K. Oka, T. Nakano, and T. Arai P53CM1 expression is not associated with prognosis in uterine cervical carcinoma Cancer 72 1993 160 164
31. S.M.F. Brenna, L.C. Zeferino, and G.A. Pinto p53 expression as a predictor of recurrence in cervical squamous cell carcinoma Int J Gynecol Cancer 12 2002 299 303
32. A. Helland, R. Holm, and G. Kristensen Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas J Pathol 171 1993 105 114
33. S. Cavuslu, J. Goodlad, and C. Hobbs Relationship between human papilloma virus infection and overexpression of p53 protein in cervical carcinomas and lymph node metastases J Med Virol 53 1997 111 117
34. E.T.M. Dejonge, E. Viljoen, and B.G. Lindeque The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy Int J Gynecol Cancer 9 1999 198 205
35. B. ter Harmsel, R. van Muyden, and F. Smedts The significance of cell type and tumor growth markers in the prognosis of unscreened cervical cancer patients Int J Gynecol Cancer 8 1998 336 344
36. H. Tsuda, and S. Hirohashi Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage with aggressive histological phenotypes Jpn J Cancer Res 83 1992 1184 1191
37. E.A. Sisk, S.G. Soltys, and S. Zhu Human papilloma virus and p53 mutational status as prognostic factors in head and neck carcinoma Head Neck 24 2002 841 849
38. T. Kihana, H. Tsuda, and S. Teshima High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy Jpn J Cancer Res 83 1992 978 984
39. C. Denk, K. Butz, and A. Schneider p53 Mutations are rare events in recurrent cervical cancer J Mol Med 79 2001 283 288
40. H. Simada, S. Okazumi, and A. Takeda Presence of serum p53 antibodies is associated with decreased in vitro chemosensitivity in patients with esophageal cancer Surg Today 31 2001 591 596
41. R. Halperin, S. Zehavi, and P. Dar Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovarian carcinomas Eur J Gynecol Oncol 22 2001 292 296
42. S. Terlikowski, A. Lenczewski, and W. Famulski Patterns of immunohistochemical staining for p53 expression in hyperplastic endometrium and adenocarcinoma Folia Histochem Cytobiol 39 2001 195 196
43. B. Powell, R. Soong, and F. Grieu p53 Protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma Int J Oncol 14 1999 175 179
44. H.B. Salvesen, O.E. Iversen, and L.A. Akslen Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study J Clinic Oncol 17 1999 1382 1390
45. T. Ohkouchi, N. Sakuragi, and H. Watari Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma Am J Obstet Gynecol 187 2002 353 359
46. C.J. Sung, Y. Zheng, and M.R. Quddus p53 As a significant prognostic marker in endometrial carcinoma Int J Gynecol Cancer 10 2000 119 127
47. R. Holm, H. Skomedal, and Å. Helland Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix utreri J Pathol 169 1993 21 26
48. J. Saito, H. Hoshiai, and K. Noda Type of human papilloma virus and expression of p53 in elderly women with cervical cancer Gynecol Obstet Invest 49 2000 190 193
49. S. Nakagawa, H. Yoshikawa, and T. Onda Type of human papilloma virus is related to clinical features of cervical carcinoma Cancer 78 1996 1935 1941
50. G.B. Kristensen, F. Karlsen, and A. Jenkins Human papilloma virus has no prognostic significance in cervical carcinoma Eur J Cancer 32A 1996 1349 1353
51. R.C.P.A. van Muyden, B.W.A. ter Harmsel, and F.M.M. Smedts Detection and typing of human papilloma virus in cervical carcinomas in Russian women: a prognostic study Cancer 85 1999 2011 2016
52. L.A. King, T. Tase, and L.B. Twiggs Prognostic significance of the presence of human papilloma virus DNA in patients with invasive carcinoma of the cervix Cancer 63 1989 897 900
53. S.M. Schwartz, J.R. Daling, and K.A. Shera Human papilloma virus and prognosis of invasive cervical cancer: a population-based study J Clin Oncol 19 2001 1906 1915
54. G. Riou, M. Favre, and D. Jeannel Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA Lancet 335 1990 1171 1174
55. B. Bachtiary, A. Obermair, and B. Dreier Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer Int J Cancer 102 2002 237 243
56. R.C. Sobti, K. Parashar, and R. Kaur Detection of human papilloma virus DNA, serum p53, and p53 antibodies in patients with cervical cancer JEPTO 21 2002 79 85
57. S. Basari, M. Roncalli, and G. Viale p53 immunoreactivity in inflammatory and neoplastic disease of the uterine cervix J Pathol 169 1993 425 430
58. J.K. Bar, A. Harlozinska, and P. Sedlaczek Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias Anticancer Res 21 2001 1001 1006
59. H.Y.S. Ngan, A.N.Y. Cheung, and S.S. Liu Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis Oncol Rep 8 2001 557 561
60. Y.C. Yang, J. Shen, and J.E. Tage Cervical cancer in young in Taiwan: prognosis is independent of papilloma virus or tumor cell type Gynecol Oncol 64 1997 59 63